Correlation Between International Business and Zynerba Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both International Business and Zynerba Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining International Business and Zynerba Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between International Business Machines and Zynerba Pharmaceuticals, you can compare the effects of market volatilities on International Business and Zynerba Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in International Business with a short position of Zynerba Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of International Business and Zynerba Pharmaceuticals.

Diversification Opportunities for International Business and Zynerba Pharmaceuticals

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between International and Zynerba is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding International Business Machine and Zynerba Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zynerba Pharmaceuticals and International Business is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on International Business Machines are associated (or correlated) with Zynerba Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zynerba Pharmaceuticals has no effect on the direction of International Business i.e., International Business and Zynerba Pharmaceuticals go up and down completely randomly.

Pair Corralation between International Business and Zynerba Pharmaceuticals

If you would invest  16,411  in International Business Machines on August 29, 2024 and sell it today you would earn a total of  6,281  from holding International Business Machines or generate 38.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy0.79%
ValuesDaily Returns

International Business Machine  vs.  Zynerba Pharmaceuticals

 Performance 
       Timeline  
International Business 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in International Business Machines are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental drivers, International Business displayed solid returns over the last few months and may actually be approaching a breakup point.
Zynerba Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zynerba Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Zynerba Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

International Business and Zynerba Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with International Business and Zynerba Pharmaceuticals

The main advantage of trading using opposite International Business and Zynerba Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if International Business position performs unexpectedly, Zynerba Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zynerba Pharmaceuticals will offset losses from the drop in Zynerba Pharmaceuticals' long position.
The idea behind International Business Machines and Zynerba Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets